{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:08:25Z","timestamp":1793138905966,"version":"4.5.0"},"reference-count":113,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Haematology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.beha.2024.101537","type":"journal-article","created":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T22:20:27Z","timestamp":1706826027000},"page":"101537","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Germline predisposition to myeloid neoplasms: Characteristics and management of high versus variable penetrance disorders"],"prefix":"10.1016","volume":"37","author":[{"given":"Amy M.","family":"Trottier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Feurstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1914-9158","authenticated-orcid":false,"given":"Lucy A.","family":"Godley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.beha.2024.101537_bib1","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/13793","article-title":"Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia","volume":"23","author":"Song","year":"1999","journal-title":"Nat Genet"},{"issue":"20","key":"10.1016\/j.beha.2024.101537_bib2","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.beha.2024.101537_bib3","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International consensus classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.beha.2024.101537_bib4","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1182\/blood.2022016867","article-title":"Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN","volume":"140","author":"D\u00f6hner","year":"2022","journal-title":"Blood"},{"issue":"21","key":"10.1016\/j.beha.2024.101537_bib5","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1182\/blood.2022015853","article-title":"Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia","volume":"140","author":"Duncavage","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.beha.2024.101537_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmg.2023.104727","article-title":"European standard clinical practice \u2013 key issues for the medical care of individuals with familial leukemia","volume":"66","author":"F\u00f6rster","year":"2023","journal-title":"Eur J Med Genet"},{"issue":"2","key":"10.1016\/j.beha.2024.101537_bib7","doi-asserted-by":"crossref","first-page":"106","DOI":"10.6004\/jnccn.2022.0009","article-title":"NCCN Guidelines\u00ae insights: myelodysplastic syndromes, version 3.2022: featured updates to the NCCN guidelines","volume":"20","author":"Greenberg","year":"2022","journal-title":"J Natl Compr Cancer Netw"},{"issue":"21","key":"10.1016\/j.beha.2024.101537_bib8","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1182\/blood-2015-11-680199","article-title":"Exome sequencing reveals recurrent germ line variants in patients with familial Waldenstr\u00f6m macroglobulinemia","volume":"127","author":"Roccaro","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.beha.2024.101537_bib9","first-page":"2324","article-title":"Exome sequencing identifies germline variants in DIS3 in familial multiple myeloma [Internet]","volume":"33","author":"Pertesi","year":"2019","journal-title":"Leukemia. Nature Publishing Group"},{"issue":"4","key":"10.1016\/j.beha.2024.101537_bib10","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/s41571-018-0136-6","article-title":"Somatic and germline genomics in paediatric acute lymphoblastic leukaemia","volume":"16","author":"Pui","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"issue":"2","key":"10.1016\/j.beha.2024.101537_bib11","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/cncr.29615","article-title":"Inherited mutations in cancer susceptibility genes are common among survivors of breast cancer who develop therapy-related leukemia","volume":"122","author":"Churpek","year":"2016","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.beha.2024.101537_bib12","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1159\/000452082","article-title":"Bloom's syndrome: clinical spectrum, molecular pathogenesis, and cancer predisposition","volume":"8","author":"Cunniff","year":"2017","journal-title":"Mol Syndromol"},{"issue":"2","key":"10.1016\/j.beha.2024.101537_bib13","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.cell.2018.03.039","article-title":"Pathogenic germline variants in 10,389 adult cancers","volume":"173","author":"Huang","year":"2018","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.beha.2024.101537_bib14","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/bjh.17247","article-title":"Inherited predisposition to haematopoietic malignancies: overcoming barriers and exploring opportunities","volume":"194","author":"Trottier","year":"2021","journal-title":"Br J Haematol"},{"issue":"14","key":"10.1016\/j.beha.2024.101537_bib15","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1182\/blood-2016-05-670240","article-title":"How I diagnose and manage individuals at risk for inherited myeloid malignancies","volume":"128","year":"2016","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.beha.2024.101537_bib16","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1053\/j.seminhematol.2017.04.001","article-title":"Familial CEBPA-mutated acute myeloid leukemia","volume":"54","author":"Tawana","year":"2017","journal-title":"Semin Hematol"},{"issue":"2","key":"10.1016\/j.beha.2024.101537_bib17","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/s41568-020-00315-z","article-title":"Advances in germline predisposition to acute leukemias and myeloid neoplasms","volume":"21","author":"Klco","year":"2021","journal-title":"Nat Rev Cancer"},{"issue":"12","key":"10.1016\/j.beha.2024.101537_bib18","doi-asserted-by":"crossref","first-page":"4639","DOI":"10.1182\/blood-2008-05-156745","article-title":"Five new pedigrees with inherited RUNX1 mutations causing familial platelet disorder with propensity to myeloid malignancy","volume":"112","author":"Owen","year":"2008","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.beha.2024.101537_bib19","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s12185-017-2259-4","article-title":"Germline ETV6 mutations and predisposition to hematological malignancies","volume":"106","author":"Feurstein","year":"2017","journal-title":"Int J Hematol"},{"issue":"10","key":"10.1016\/j.beha.2024.101537_bib20","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1182\/blood-2015-05-647172","article-title":"Disease evolution and outcomes in familial AML with germline CEBPA mutations","volume":"126","author":"Tawana","year":"2015","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.beha.2024.101537_bib21","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1182\/blood-2013-07-515528","article-title":"GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity","volume":"123","author":"Spinner","year":"2014","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.beha.2024.101537_bib22","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1053\/j.seminhematol.2017.05.002","article-title":"GATA2 deficiency and related myeloid neoplasms","volume":"54","author":"Wlodarski","year":"2017","journal-title":"Semin Hematol"},{"key":"10.1016\/j.beha.2024.101537_bib23","series-title":"Molecular hematology. Fourth","first-page":"37","article-title":"The genetics of acute myeloid leukemias","author":"Trottier","year":"2019"},{"issue":"23","key":"10.1016\/j.beha.2024.101537_bib24","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1056\/NEJMoa041331","article-title":"Mutation of CEBPA in familial acute myeloid leukemia","volume":"351","author":"Smith","year":"2004","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.beha.2024.101537_bib25","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1182\/blood-2010-09-307280","article-title":"Prognostic impact, concurrent genetic mutations, and gene expression features of AML with CEBPA mutations in a cohort of 1182 cytogenetically normal AML patients: further evidence for CEBPA double mutant AML as a distinctive disease entity","volume":"117","author":"Taskesen","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.beha.2024.101537_bib26","doi-asserted-by":"crossref","first-page":"5088","DOI":"10.1200\/JCO.2008.16.5563","article-title":"Somatic CEBPA mutations are a frequent second event in families with germline CEBPA mutations and familial acute myeloid leukemia","volume":"26","author":"Pabst","year":"2008","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.beha.2024.101537_bib27","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1038\/s41375-022-01515-2","article-title":"Acquired somatic variants in inherited myeloid malignancies","volume":"36","author":"Armes","year":"2022","journal-title":"Leukemia"},{"issue":"7","key":"10.1016\/j.beha.2024.101537_bib28","first-page":"599","article-title":"Companion gene mutations and their clinical significance in AML with double mutant CEBPA","volume":"27","author":"Zhang","year":"2019","journal-title":"Cancer Gene Ther"},{"issue":"7","key":"10.1016\/j.beha.2024.101537_bib29","doi-asserted-by":"crossref","first-page":"846","DOI":"10.3324\/haematol.2015.130799","article-title":"Whole exome sequencing reveals a C-terminal germline variant in CEBPA-associated acute myeloid leukemia: 45-year follow up of a large family","volume":"101","author":"Pathak","year":"2016","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.beha.2024.101537_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-14829-5","article-title":"The complex genetic landscape of familial MDS and AML reveals pathogenic germline variants","volume":"11","author":"Rio-Machin","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.beha.2024.101537_bib31","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s10689-023-00329-0","article-title":"Hereditary acute myeloid leukemia associated with C-terminal CEBPA germline variants","volume":"22","author":"Harrigan","year":"2023","journal-title":"Fam Cancer"},{"issue":"1","key":"10.1016\/j.beha.2024.101537_bib32","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1182\/blood.2019000937","article-title":"Secondary leukemia in patients with germline transcription factor mutations (RUNX1, GATA2, CEBPA)","volume":"136","author":"Brown","year":"2020","journal-title":"Blood"},{"issue":"21","key":"10.1016\/j.beha.2024.101537_bib33","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1182\/blood.2019003357","article-title":"High frequency of germline RUNX1 mutations in patients with RUNX1-mutated AML","volume":"135","author":"Simon","year":"2020","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.beha.2024.101537_bib34","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.3109\/10428194.2011.638718","article-title":"A novel CCAAT\/enhancer binding protein \u03b1 germline variant in a case of acute myeloid leukemia","volume":"53","author":"Gutman","year":"2012","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"10.1016\/j.beha.2024.101537_bib35","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1182\/blood-2012-01-403220","article-title":"GATA2 zinc finger 1 mutations associated with biallelic CEBPA mutations define a unique genetic entity of acute myeloid leukemia","volume":"120","author":"Greif","year":"2012","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.beha.2024.101537_bib36","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1038\/ng.913","article-title":"Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia","volume":"43","author":"Hahn","year":"2011","journal-title":"Nat Genet"},{"issue":"11","key":"10.1016\/j.beha.2024.101537_bib37","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1182\/blood-2015-09-669937","article-title":"Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents","volume":"127","author":"Wlodarski","year":"2016","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.beha.2024.101537_bib38","doi-asserted-by":"crossref","first-page":"707","DOI":"10.3324\/haematol.2015.137711","article-title":"Loss of B cells and their precursors is the most constant feature of GATA-2 deficiency in childhood myelodysplastic syndrome","volume":"101","author":"Nov\u00e1kov\u00e1","year":"2016","journal-title":"Haematologica"},{"issue":"8","key":"10.1016\/j.beha.2024.101537_bib39","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1038\/s41375-021-01137-0","article-title":"Germline variants drive myelodysplastic syndrome in young adults","volume":"35","author":"Feurstein","year":"2021","journal-title":"Leukemia"},{"issue":"10","key":"10.1016\/j.beha.2024.101537_bib40","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1038\/s41375-020-0899-5","article-title":"Synonymous GATA2 mutations result in selective loss of mutated RNA and are common in patients with GATA2 deficiency","volume":"34","author":"Kozyra","year":"2020","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.beha.2024.101537_bib41","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/bjh.12317","article-title":"GATA2 mutations in sporadic and familial acute myeloid leukaemia patients with CEBPA mutations","volume":"161","author":"Green","year":"2013","journal-title":"Br J Haematol"},{"issue":"9","key":"10.1016\/j.beha.2024.101537_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41408-018-0123-2","article-title":"GATA2 zinc finger 1 mutations are associated with distinct clinico-biological features and outcomes different from GATA2 zinc finger 2 mutations in adult acute myeloid leukemia","volume":"8","author":"Tien","year":"2018","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.beha.2024.101537_bib43","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/01.HS9.0000843540.79454.e1","article-title":"Somatic genetic landscape in GATA2 deficiency patients","volume":"6","author":"Largeaud","year":"2022","journal-title":"HemaSphere"},{"issue":"3","key":"10.1016\/j.beha.2024.101537_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.beha.2020.101197","article-title":"Germline predisposition in myeloid neoplasms: unique genetic and clinical features of GATA2 deficiency and SAMD9\/SAMD9L syndromes","volume":"33","author":"Sahoo","year":"2020","journal-title":"Best Pract Res Clin Haematol"},{"issue":"7","key":"10.1016\/j.beha.2024.101537_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/EVIDoa2200008","article-title":"Molecular international prognostic scoring system for myelodysplastic syndromes","volume":"1","author":"Bernard","year":"2022","journal-title":"NEJM Evid"},{"issue":"11","key":"10.1016\/j.beha.2024.101537_bib46","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1038\/s41375-021-01212-6","article-title":"Pediatric MDS and bone marrow failure-associated germline mutations in SAMD9 and SAMD9L impair multiple pathways in primary hematopoietic cells","volume":"35","author":"Thomas","year":"2021","journal-title":"Leuk"},{"issue":"16","key":"10.1016\/j.beha.2024.101537_bib47","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1182\/blood-2016-10-743302","article-title":"Gain-of-function SAMD9L mutations cause a syndrome of cytopenia, immunodeficiency, MDS, and neurological symptoms","volume":"129","author":"Tesi","year":"2017","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.beha.2024.101537_bib48","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/ng.3569","article-title":"SAMD9 mutations cause a novel multisystem disorder, MIRAGE syndrome, and are associated with loss of chromosome 7","volume":"48","author":"Narumi","year":"2016","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.beha.2024.101537_bib49","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3324\/haematol.2017.180778","article-title":"Constitutional SAMD9L mutations cause familial myelodysplastic syndrome and transient monosomy 7","volume":"103","author":"Pastor","year":"2018","journal-title":"Haematologica"},{"issue":"Supplement 1","key":"10.1016\/j.beha.2024.101537_bib50","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1182\/blood-2018-99-118389","article-title":"SAMD9 and SAMD9L germline disorders in patients enrolled in studies of the European working group of MDS in childhood (EWOG-MDS): prevalence, outcome, phenotype and functional characterisation","volume":"132","author":"Sahoo","year":"2018","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.beha.2024.101537_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-017-01590-5","article-title":"The genomic landscape of pediatric myelodysplastic syndromes","volume":"8","author":"Schwartz","year":"2017","journal-title":"Nat Commun"},{"issue":"11","key":"10.1016\/j.beha.2024.101537_bib52","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1016\/j.bbmt.2019.07.007","article-title":"Outcomes of hematopoietic cell transplantation in patients with germline SAMD9\/SAMD9L mutations","volume":"25","author":"Ahmed","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"10.1016\/j.beha.2024.101537_bib53","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1182\/bloodadvances.2017012682","article-title":"Poor outcome with hematopoietic stem cell transplantation for bone marrow failure and MDS with severe MIRAGE syndrome phenotype Key Points","volume":"2","author":"Sarthy","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.beha.2024.101537_bib54","series-title":"Li-fraumeni syndrome","author":"Schneider","year":"2019"},{"issue":"15","key":"10.1016\/j.beha.2024.101537_bib55","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1038\/sj.onc.1210302","article-title":"TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes","volume":"26","author":"Petitjean","year":"2007","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.beha.2024.101537_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/mcs.a003210","article-title":"Hematologic malignancies and Li\u2013Fraumeni syndrome","volume":"5","author":"Swaminathan","year":"2019","journal-title":"Cold Spring Harb Mol Case Stud"},{"issue":"7540","key":"10.1016\/j.beha.2024.101537_bib57","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/nature13968","article-title":"Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia","volume":"518","author":"Wong","year":"2015","journal-title":"Nature"},{"issue":"18","key":"10.1016\/j.beha.2024.101537_bib58","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1182\/blood-2016-08-732610","article-title":"Acute myeloid leukemia with TP53 germ line mutations","volume":"128","author":"Zebisch","year":"2016","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.beha.2024.101537_bib59","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1158\/1078-0432.CCR-17-0408","article-title":"Cancer screening recommendations for individuals with Li-fraumeni syndrome","volume":"23","author":"Kratz","year":"2017","journal-title":"Clin Cancer Res"},{"issue":"9","key":"10.1016\/j.beha.2024.101537_bib60","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S1470-2045(16)30249-2","article-title":"Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational study","volume":"17","author":"Villani","year":"2016","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.beha.2024.101537_bib61","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/s41409-019-0624-z","article-title":"Death after hematopoietic stem cell transplantation: changes over calendar year time, infections and associated factors","volume":"55","author":"Styczy\u0144ski","year":"2019","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.beha.2024.101537_bib62","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/ACI.0000000000000126","article-title":"GATA2 deficiency","volume":"15","author":"Hsu","year":"2015","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.beha.2024.101537_bib63","series-title":"MIRAGE syndrome","author":"Tanase-Nakao","year":"2020"},{"key":"10.1016\/j.beha.2024.101537_bib64","article-title":"SAMD9L ataxia-pancytopenia syndrome","author":"Phowthongkum","year":"2021","journal-title":"GeneReviews\u00ae."},{"issue":"24","key":"10.1016\/j.beha.2024.101537_bib65","doi-asserted-by":"crossref","first-page":"6673","DOI":"10.1182\/blood-2011-02-336537","article-title":"Mutations in ANKRD26 are responsible for a frequent form of inherited thrombocytopenia: analysis of 78 patients from 21 families","volume":"117","author":"Noris","year":"2011","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.beha.2024.101537_bib66","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1182\/blood-2013-04-499319","article-title":"ANKRD26-related thrombocytopenia and myeloid malignancies","volume":"122","author":"Noris","year":"2013","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.beha.2024.101537_bib67","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3324\/haematol.2016.147694","article-title":"Germline variants in ETV6 underlie reduced platelet formation, platelet dysfunction and increased levels of circulating CD34+ progenitors","volume":"102","author":"Poggi","year":"2017","journal-title":"Haematologica"},{"issue":"8","key":"10.1016\/j.beha.2024.101537_bib68","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1182\/blood.2019852418","article-title":"ETV6-related thrombocytopenia and leukemia predisposition","volume":"134","author":"Paola","year":"2019","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.beha.2024.101537_bib69","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1182\/bloodadvances.2019000901","article-title":"RUNX1-mutated families show phenotype heterogeneity and a somatic mutation profile unique to germline predisposed AML","volume":"4","author":"Brown","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.beha.2024.101537_bib70","first-page":"131","article-title":"Inherited thrombocytopenia and platelet disorders with germline predisposition to myeloid neoplasia [Internet]","volume":"41","author":"Galera","year":"2019","journal-title":"Int J Lit Humanit"},{"issue":"15","key":"10.1016\/j.beha.2024.101537_bib71","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1182\/blood-2016-10-687830","article-title":"Role of RUNX1 in hematological malignancies","volume":"129","author":"Sood","year":"2017","journal-title":"Blood"},{"issue":"50","key":"10.1016\/j.beha.2024.101537_bib72","doi-asserted-by":"crossref","first-page":"21719","DOI":"10.1073\/pnas.1006981107","article-title":"Genetic landscape of high hyperdiploid childhood acute lymphoblastic leukemia","volume":"107","author":"Paulsson","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.beha.2024.101537_bib73","article-title":"Genomic landscape of patients with germline RUNX1 variants and familial platelet disorder with myeloid malignancy","author":"Yu","year":"2023","journal-title":"bioRxiv"},{"issue":"5","key":"10.1016\/j.beha.2024.101537_bib74","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/bjh.15990","article-title":"Longitudinal sequencing of RUNX1 familial platelet disorder: new insights into genetic mechanisms of transformation to myeloid malignancies","volume":"186","author":"Duarte","year":"2019","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.beha.2024.101537_bib75","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1038\/leu.2015.236","article-title":"Somatic mutations associated with leukemic progression of familial platelet disorder with predisposition to acute myeloid leukemia","volume":"30","author":"Antony-Debr\u00e9","year":"2016","journal-title":"Leukemia"},{"issue":"15","key":"10.1016\/j.beha.2024.101537_bib76","doi-asserted-by":"crossref","first-page":"4357","DOI":"10.1182\/bloodadvances.2022007211","article-title":"Clonal hematopoiesis in patients with ANKRD26 or ETV6 germline mutations","volume":"6","author":"Drazer","year":"2022","journal-title":"Blood Adv"},{"issue":"1","key":"10.1016\/j.beha.2024.101537_bib77","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/bjh.14746","article-title":"Clinical spectrum and clonal evolution in germline syndromes with predisposition to myeloid neoplasms","volume":"182","author":"Perez Botero","year":"2018","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.beha.2024.101537_bib78","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s12185-017-2260-y","article-title":"Myeloid neoplasms with germline DDX41 mutation","volume":"106","author":"Cheah","year":"2017","journal-title":"Int J Hematol"},{"issue":"3","key":"10.1016\/j.beha.2024.101537_bib79","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/s41375-021-01404-0","article-title":"AML with germline DDX41 variants is a clinicopathologically distinct entity with an indolent clinical course and favorable outcome","volume":"36","author":"Li","year":"2021","journal-title":"Leuk"},{"key":"10.1016\/j.beha.2024.101537_bib80","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/20406207211032433","article-title":"Clinical features of DDX41 mutation-related diseases: a systematic review with individual patient data","volume":"12","author":"Wan","year":"2021","journal-title":"Ther Adv Hematol"},{"issue":"5","key":"10.1016\/j.beha.2024.101537_bib81","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1182\/blood.2022018221","article-title":"Germline DDX41 mutations define a unique subtype of myeloid neoplasms","volume":"141","author":"Makishima","year":"2023","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.beha.2024.101537_bib82","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1182\/blood.2021013523","article-title":"Disease progression and clinical outcomes in telomere biology disorders","volume":"139","author":"Niewisch","year":"2022","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.beha.2024.101537_bib83","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/cge.13370","article-title":"Refining the phenotype associated with biallelic DNAJC21 mutations","volume":"94","author":"D'Amours","year":"2018","journal-title":"Clin Genet"},{"issue":"11","key":"10.1016\/j.beha.2024.101537_bib84","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1182\/blood-2016-08-735431","article-title":"Biallelic mutations in DNAJC21 cause Shwachman-Diamond syndrome","volume":"129","author":"Dhanraj","year":"2017","journal-title":"Blood"},{"issue":"15","key":"10.1016\/j.beha.2024.101537_bib85","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1182\/blood.2020009111","article-title":"Analysis of disease model iPSCs derived from patients with a novel Fanconi anemia-like IBMFS ADH5\/ALDH2 deficiency","volume":"137","author":"Mu","year":"2021","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.beha.2024.101537_bib86","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-022-28242-7","article-title":"Endogenous formaldehyde scavenges cellular glutathione resulting in redox disruption and cytotoxicity","volume":"13","author":"Umansky","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.beha.2024.101537_bib87","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1182\/asheducation-2004.1.318","author":"Bagby","year":"2004","journal-title":"Marrow failure. Hematol Am Soc Hematol Educ Progr."},{"issue":"6","key":"10.1016\/j.beha.2024.101537_bib88","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.molcel.2020.10.012","article-title":"Two aldehyde clearance systems are essential to prevent lethal formaldehyde accumulation in mice and humans","volume":"80","author":"Dingler","year":"2020","journal-title":"Mol Cell"},{"issue":"7","key":"10.1016\/j.beha.2024.101537_bib89","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1182\/blood-2017-09-806489","article-title":"A landscape of germ line mutations in a cohort of inherited bone marrow failure patients","volume":"131","author":"Bluteau","year":"2018","journal-title":"Blood"},{"issue":"24","key":"10.1016\/j.beha.2024.101537_bib90","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1182\/blood.2022015790","article-title":"Germ line predisposition variants occur in myelodysplastic syndrome patients of all ages","volume":"140","author":"Feurstein","year":"2022","journal-title":"Blood"},{"issue":"30","key":"10.1016\/j.beha.2024.101537_bib91","doi-asserted-by":"crossref","first-page":"7777","DOI":"10.1073\/pnas.1803275115","article-title":"Genome instability is a consequence of transcription deficiency in patients with bone marrow failure harboring biallelic ERCC6L2 variants","volume":"115","author":"Tummala","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"10.1016\/j.beha.2024.101537_bib92","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1111\/apa.16005","article-title":"Kostmann disease and other forms of severe congenital neutropenia","volume":"110","author":"Fadeel","year":"2021","journal-title":"Acta Paediatr"},{"issue":"9","key":"10.1016\/j.beha.2024.101537_bib93","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.3324\/haematol.2011.057489","article-title":"Classification of and risk factors for hematologic complications in a French national cohort of 102 patients with Shwachman-Diamond syndrome","volume":"97","author":"Donadieu","year":"2012","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.beha.2024.101537_bib94","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ajhg.2016.05.002","article-title":"DNAJC21 mutations link a cancer-prone bone marrow failure syndrome to corruption in 60S ribosome subunit maturation","volume":"99","author":"Tummala","year":"2016","journal-title":"Am J Hum Genet"},{"issue":"1","key":"10.1016\/j.beha.2024.101537_bib95","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3324\/haematol.2017.178111","article-title":"Cancer in the National Cancer Institute inherited bone marrow failure syndrome cohort after fifteen years of follow-up","volume":"103","author":"Alter","year":"2018","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.beha.2024.101537_bib96","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.3324\/haematol.2017.178723","article-title":"MDS1 and EVI1 complex locus (MECOM): a novel candidate gene for hereditary hematological malignancies","volume":"103","author":"Ripperger","year":"2018","journal-title":"Haematologica"},{"issue":"7","key":"10.1016\/j.beha.2024.101537_bib97","doi-asserted-by":"crossref","first-page":"e284","DOI":"10.3324\/haematol.2017.183855","article-title":"Expanding the phenotypic and genetic spectrum of radioulnar synostosis associated hematological disease","volume":"103","author":"Walne","year":"2018","journal-title":"Haematologica"},{"issue":"10","key":"10.1016\/j.beha.2024.101537_bib98","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1080\/17474086.2021.1977119","article-title":"Hematopoietic stem cell transplantation for classical inherited bone marrow failure syndromes: an update","volume":"14","author":"Pierri","year":"2021","journal-title":"Expert Rev Hematol"},{"issue":"1","key":"10.1016\/j.beha.2024.101537_bib99","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-021-21588-4","article-title":"Distinct genetic pathways define pre-malignant versus compensatory clonal hematopoiesis in Shwachman-Diamond syndrome","volume":"12","author":"Kennedy","year":"2021","journal-title":"Nat Commun"},{"issue":"15","key":"10.1016\/j.beha.2024.101537_bib100","doi-asserted-by":"crossref","first-page":"e161","DOI":"10.1182\/blood-2010-09-308726","article-title":"Myelodysplasia and leukemia of Fanconi anemia are associated with a specific pattern of genomic abnormalities that includes cryptic RUNX1\/AML1 lesions","volume":"117","author":"Quentin","year":"2011","journal-title":"Blood"},{"issue":"22","key":"10.1016\/j.beha.2024.101537_bib101","doi-asserted-by":"crossref","first-page":"6047","DOI":"10.1182\/blood-2011-03-343897","article-title":"Fanconi anemia (FA)-associated 3q gains in leukemic transformation consistently target EVI1, but do not affect low TERC expression in FA","volume":"117","author":"Meyer","year":"2011","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.beha.2024.101537_bib102","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1309\/AJCP7W9VMJENZOVG","article-title":"Diagnosis of myelodysplastic syndrome among a cohort of 119 patients with fanconi anemia: morphologic and cytogenetic characteristics","volume":"133","author":"Cioc","year":"2010","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"10.1016\/j.beha.2024.101537_bib103","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/MOH.0000000000000479","article-title":"Mechanisms of leukemic transformation in congenital neutropenia","volume":"26","author":"Link","year":"2019","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.beha.2024.101537_bib104","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2022-167098","article-title":"Allogeneic hematopoietic stem cell transplant outcomes in adults with inherited myeloid malignancies","author":"Saygin","year":"2022","journal-title":"Blood Adv"},{"issue":"3","key":"10.1016\/j.beha.2024.101537_bib105","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1053\/j.seminhematol.2022.07.002","article-title":"Somatic compensation of inherited bone marrow failure","volume":"59","author":"Lundgren","year":"2022","journal-title":"Semin Hematol"},{"issue":"8","key":"10.1016\/j.beha.2024.101537_bib106","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1007\/s00277-015-2370-7","article-title":"Outcomes of mismatched and unrelated donor hematopoietic stem cell transplantation in Fanconi anemia conditioned with chemotherapy only","volume":"94","author":"Chao","year":"2015","journal-title":"Ann Hematol"},{"issue":"4","key":"10.1016\/j.beha.2024.101537_bib107","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s12185-016-1951-0","article-title":"Allogeneic hematopoietic stem cell transplantation for inherited bone marrow failure syndromes","volume":"103","author":"Dalle","year":"2016","journal-title":"Int J Hematol"},{"issue":"10","key":"10.1016\/j.beha.2024.101537_bib108","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1182\/blood.2021011075","article-title":"The clinical and functional effects of TERT variants in myelodysplastic syndrome","volume":"138","author":"Reilly","year":"2021","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.beha.2024.101537_bib109","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1182\/blood.2022016508","article-title":"Genetic testing in severe aplastic anemia is required for optimal hematopoietic cell transplant outcomes","volume":"140","author":"McReynolds","year":"2022","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.beha.2024.101537_bib110","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/leu.2017.44","article-title":"Donor cell leukemia arising from preleukemic clones with a novel germline DDX41 mutation after allogenic hematopoietic stem cell transplantation","volume":"31","author":"Kobayashi","year":"2017","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.beha.2024.101537_bib111","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/j.bbmt.2016.08.002","article-title":"Identifying inherited and acquired genetic factors involved in poor stem cell mobilization and donor-derived malignancy","volume":"22","author":"Rojek","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"19","key":"10.1016\/j.beha.2024.101537_bib112","doi-asserted-by":"crossref","first-page":"5257","DOI":"10.1182\/blood-2010-12-326322","article-title":"First report of multiple CEBPA mutations contributing to donor origin of leukemia relapse after allogeneic hematopoietic stem cell transplantation","volume":"117","author":"Xiao","year":"2011","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.beha.2024.101537_bib113","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/leu.2016.310","article-title":"Re-emergence of acute myeloid leukemia in donor cells following allogeneic transplantation in a family with a germline DDX41 mutation","volume":"31","author":"Berger","year":"2017","journal-title":"Leukemia"}],"container-title":["Best Practice &amp; Research Clinical Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692624000021?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692624000021?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:08:48Z","timestamp":1761498528000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521692624000021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":113,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S1521692624000021"],"URL":"https:\/\/doi.org\/10.1016\/j.beha.2024.101537","relation":{},"ISSN":["1521-6926"],"issn-type":[{"value":"1521-6926","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Germline predisposition to myeloid neoplasms: Characteristics and management of high versus variable penetrance disorders","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Haematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beha.2024.101537","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101537"}}